The typical case for the fund is to invest in rounds with 5 participants. The meaningful sponsors for the fund in investment in the same round are Quan Capital, Qiming Venture Partners, New Horizon Capital.
The common things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2017. The fund is constantly included in less than 2 investment rounds annually.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most successful fund investment fields, there are Health Care, Pharmaceutical. Among the various public portfolio startups of the fund, we may underline Qiagen Suzhou Translational Medicine
| Fund Name | Location |
| 15th Rock Ventures | Japan, Tokyo |
| A-Round Capital | - |
| Bauer Venture Partners | Germany, Hamburg |
| Canary Ventures | Canarias, Las Palmas, Spain |
| Gotham Green Partners | California, Santa Monica, United States |
| Holly Group Holdings | China, Hong Kong, Hong Kong Island |
| Jiangyi Chuangtou | China, Japan, Kagoshima Prefecture |
| Kamunting Street Capital | - |
| Kendall Family Foundation | Boston, Massachusetts, United States |
| Neome | Herzliya, Israel, Tel Aviv |
| Pergament LOHAS Fund | New York, New York, United States |
| PMC Partners | England, London, United Kingdom |
| Southwestern Ontario Development Fund | - |
| Sprout Venture Partners | Bangalore, India, Karnataka |
| Thai Union Group | Samut Sakhon, Samut Sakhon Province, Thailand |
| TRIREC | Central Region, Singapore, Singapore |
| Venture Technologies | Mississippi, Ridgeland, United States |
| Zhongke Venture Capital | China, Guangdong, Shenzhen |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Qiagen Suzhou Translational Medicine | $27M | 07 Jul 2017 | Jiangsu |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Qiagen Suzhou Translational Medicine | $27M | 07 Jul 2017 | Jiangsu |
